Acta Med. 2011, 54: 177-179

https://doi.org/10.14712/18059694.2016.46

Sorafenib, Risk of Bleeding and Spontaneous Rupture of Hepatocellular Carcinoma. A Clinical Case

Ferdinando Rombolàa, Angelo Caravettab, Francesco Molloc, Antonio Spinosod, Lenino Pelusoc, Raffaele Guarinob

aEmergency Medicine Unit, “Jazzolino” Hospital, Vibo Valentia, and Postgraduate Internal Medicine School, Faculty of Medicine, University of Messina, Italy
bGeneral Surgery Unit, “Beato Angelo” Hospital, Acri, Cosenza, Italy
cEmergency Unit, “Beato Angelo” Hospital, Acri, Cosenza, Italy
dOncology Unit, ASP Vibo Valentia, Italy

Received November 12, 2010
Accepted October 27, 2011

References

1. Cabibbo G, Craxì A. Epidemiology, risk factors and surveillance of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci 2010; 14: 352–5.
2. Kim YI, Ki HS, Kim MH, et al. [Analysis of the clinical characteristics and prognostic factors of ruptured hepatocellular carcinoma]. Korean J Hepatol 2009; 15: 148–58. <https://doi.org/10.3350/kjhep.2009.15.2.148>
3. Vergara V, Muratore A, Bouzari H, et al. Spontaneous rupture of hepatocellular carcinoma: surgical resection and long term survival. Eur J Surg Oncol; 2000; 26: 770–2. <https://doi.org/10.1053/ejso.2000.1001>
4. Miyamoto M, Sudo T, Kuyama T. Spontaneous rupture of hepatocellular carcinoma: a review of 172 Japanese cases. Am J Gastroenterol 1991; 86: 67–71.
5. Yeh CN, Lee WC, Jeng LB, Chen MF, Yu MC. Spontaneous tumour rupture and prognosis in patients with hepatocellular carcinoma. Br J Surg 2002; 89: 1125–9. <https://doi.org/10.1046/j.1365-2168.2002.02188.x>
6. Tan FL, Tan YM, Chung AY, Cheow PC, Chow PK, Ooi LL. Factors affecting early mortality in spontaneous rupture of hepatocellular carcinoma. ANZ J Surg 2006; 76: 448–52. <https://doi.org/10.1111/j.1445-2197.2006.03750.x>
7. Kirikoshi H, Saito S, Yoneda M, et al. Outcomes and factors influencing survival in cirrhotic cases with spontaneous rupture of hepatocellular carcinoma: a multicenter study. BMC Gastroenterol 2009; 9: 29. <https://doi.org/10.1186/1471-230X-9-29> <PubMed>
8. Lai EC, Lau WY. Spontaneous rupture of hepatocellular carcinoma: a systematic review. Arch Surg 2006; 141: 191–8. <https://doi.org/10.1001/archsurg.141.2.191>
9. Choi BG, Park SH, Byun JY, Jung SE, Choi KH, Han JY. The findings of ruptured hepatocellular carcinoma on helical CT. Br J Radiol 2001; 74: 142–6. <https://doi.org/10.1259/bjr.74.878.740142>
10. Vivarelli M, Cavallari A, Bellusci R, De Raffaele E, Nardo B, Gozzetti G. Ruptured hepatocellular carcinoma: an important cause of spontaneous haemoperitoneum in Italy. Eur J Surg 1995; 161: 881–6.
11. Battula N, Madanur M, Priest O, et al. Spontaneous rupture of hepatocellular carcinoma: a Western experience. Am J Surg 2009; 197: 164–7. <https://doi.org/10.1016/j.amjsurg.2007.10.016>
12. Bassi N, Caratozzolo E, Bonariol L, et al. Management of ruptured hepatocellular carcinoma: Implications for therapy. World J Gastroenterol 2010; 16: 1221–5. <https://doi.org/10.3748/wjg.v16.i10.1221> <PubMed>
13. Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378–90. <https://doi.org/10.1056/NEJMoa0708857>
14. Je Y, Schutz FAB, Choueiri TK. Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials. Lancet Oncol 2009; 10: 967–74. <https://doi.org/10.1016/S1470-2045(09)70222-0>
15. Kamba T, McDonald DM. Mechanism of adverse effects of anti-VEGF therapy for cancer. Br J Cancer 2007; 96: 1788–95. <https://doi.org/10.1038/sj.bjc.6603813> <PubMed>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive